-
1
-
-
33744952176
-
Clinical review: adrenocortical carcinoma: clinical update
-
(doi:10.1210/jc.2005-2639)
-
Allolio B & Fassnacht M 2006 Clinical review: adrenocortical carcinoma: clinical update. Journal of Clinical Endocrinology and Metabolism 91 2027-2037. (doi:10.1210/jc.2005-2639)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, pp. 2027-2037
-
-
Allolio, B.1
Fassnacht, M.2
-
2
-
-
0034465602
-
The nuclear corepressors recognize distinct nuclear receptor complexes
-
(doi:10.1210/me.14.6.900)
-
Cohen RN, Putney A, Wondisford FE & Hollenberg AN 2000 The nuclear corepressors recognize distinct nuclear receptor complexes. Molecular Endocrinology 14 900-914. (doi:10.1210/me.14.6.900)
-
(2000)
Molecular Endocrinology
, vol.14
, pp. 900-914
-
-
Cohen, R.N.1
Putney, A.2
Wondisford, F.E.3
Hollenberg, A.N.4
-
3
-
-
0022685096
-
Influence of mitotane on the hypoprothrombinemic effect of warfarin
-
(doi:10.1097/00007611-198603000-00037)
-
Cuddy PG & Loftus LS 1986 Influence of mitotane on the hypoprothrombinemic effect of warfarin. Southern Medical Journal 79 387-388. (doi:10.1097/00007611-198603000-00037)
-
(1986)
Southern Medical Journal
, vol.79
, pp. 387-388
-
-
Cuddy, P.G.1
Loftus, L.S.2
-
4
-
-
79953193793
-
Mitotane has a strong and a durable inducing effect on CYP3A4 activity
-
(doi:10.1530/EJE-10-0956)
-
van Erp NP, Guchelaar HJ, Ploeger BA, Romijn JA, Hartigh J & Gelderblom H 2011 Mitotane has a strong and a durable inducing effect on CYP3A4 activity. European Journal of Endocrinology 164 621-626. (doi:10.1530/EJE-10-0956)
-
(2011)
European Journal of Endocrinology
, vol.164
, pp. 621-626
-
-
van Erp, N.P.1
Guchelaar, H.J.2
Ploeger, B.A.3
Romijn, J.A.4
Hartigh, J.5
Gelderblom, H.6
-
5
-
-
84861888600
-
Combination chemotherapy in advanced adrenocortical carcinoma
-
(doi:10.1056/NEJMoa1200966)
-
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B et al. 2012 Combination chemotherapy in advanced adrenocortical carcinoma. New England Journal of Medicine 366 2189-2197. (doi:10.1056/NEJMoa1200966)
-
(2012)
New England Journal of Medicine
, vol.366
, pp. 2189-2197
-
-
Fassnacht, M.1
Terzolo, M.2
Allolio, B.3
Baudin, E.4
Haak, H.5
Berruti, A.6
Welin, S.7
Schade-Brittinger, C.8
Lacroix, A.9
Jarzab, B.10
-
6
-
-
0015008520
-
Effects of o,p0-DDD on cortisol and 6-beta-hydroxycortisol secretion and metabolism in man
-
(doi:10.1210/jcem-32-2-192)
-
Fukushima DK, Bradlow HL & Hellman L 1971 Effects of o,p0-DDD on cortisol and 6-beta-hydroxycortisol secretion and metabolism in man. Journal of Clinical Endocrinology and Metabolism 32 192-200. (doi:10.1210/jcem-32-2-192)
-
(1971)
Journal of Clinical Endocrinology and Metabolism
, vol.32
, pp. 192-200
-
-
Fukushima, D.K.1
Bradlow, H.L.2
Hellman, L.3
-
7
-
-
78649576502
-
Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism
-
(doi:10.1124/dmd.110. 035568)
-
Gao J & Xie W 2010 Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism. Drug Metabolism and Disposition 38 2091-2095. (doi:10.1124/dmd.110. 035568)
-
(2010)
Drug Metabolism and Disposition
, vol.38
, pp. 2091-2095
-
-
Gao, J.1
Xie, W.2
-
8
-
-
0032702726
-
The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module
-
Goodwin B, Hodgson E & Liddle C 1999 The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Molecular Pharmacology 56 1329-1339.
-
(1999)
Molecular Pharmacology
, vol.56
, pp. 1329-1339
-
-
Goodwin, B.1
Hodgson, E.2
Liddle, C.3
-
9
-
-
0024390153
-
Hepatic microsomal enzyme induction and adrenal crisis due to o,p'DDD therapy for metastatic adrenocortical carcinoma
-
(doi:10.1111/j.1365-2265.1989.tb00453.x)
-
Hague RV, May W & Cullen DR 1989 Hepatic microsomal enzyme induction and adrenal crisis due to o,p'DDD therapy for metastatic adrenocortical carcinoma. Clinical Endocrinology 31 51-57. (doi:10.1111/j.1365-2265.1989.tb00453.x)
-
(1989)
Clinical Endocrinology
, vol.31
, pp. 51-57
-
-
Hague, R.V.1
May, W.2
Cullen, D.R.3
-
10
-
-
37549004782
-
HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans
-
(doi:10.1124/dmd.107.017418)
-
Kanebratt KP & Andersson TB 2008 HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans. Drug Metabolism and Disposition 36 137-145. (doi:10.1124/dmd.107.017418)
-
(2008)
Drug Metabolism and Disposition
, vol.36
, pp. 137-145
-
-
Kanebratt, K.P.1
Andersson, T.B.2
-
11
-
-
0036799870
-
The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism
-
(doi:10.1210/er.2001-0038)
-
Kliewer SA, Goodwin B & Willson TM 2002 The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocrine Reviews 23 687-702. (doi:10.1210/er.2001-0038)
-
(2002)
Endocrine Reviews
, vol.23
, pp. 687-702
-
-
Kliewer, S.A.1
Goodwin, B.2
Willson, T.M.3
-
12
-
-
80054769146
-
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
-
(doi:10.1111/j.1365-2265.2011.04214.x)
-
Kroiss M, Quinkler M, Lutz WK, Allolio B & Fassnacht M 2011 Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma. Clinical Endocrinology 75 585-591. (doi:10.1111/j.1365-2265.2011.04214.x)
-
(2011)
Clinical Endocrinology
, vol.75
, pp. 585-591
-
-
Kroiss, M.1
Quinkler, M.2
Lutz, W.K.3
Allolio, B.4
Fassnacht, M.5
-
13
-
-
0037931737
-
Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes
-
(doi:10.1074/jbc. M300138200)
-
Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM et al. 2003 Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. Journal of Biological Chemistry 278 17277-17283. (doi:10.1074/jbc. M300138200)
-
(2003)
Journal of Biological Chemistry
, vol.278
, pp. 17277-17283
-
-
Maglich, J.M.1
Parks, D.J.2
Moore, L.B.3
Collins, J.L.4
Goodwin, B.5
Billin, A.N.6
Stoltz, C.A.7
Kliewer, S.A.8
Lambert, M.H.9
Willson, T.M.10
-
14
-
-
15744384408
-
Transcriptional induction of CYP3A4 by o,p0-DDT in HepG2 cells
-
(doi:10.1016/ j.toxlet.2005.01.003)
-
Medina-Diaz IM & Elizondo G 2005 Transcriptional induction of CYP3A4 by o,p0-DDT in HepG2 cells. Toxicology Letters 157 41-47. (doi:10.1016/ j.toxlet.2005.01.003)
-
(2005)
Toxicology Letters
, vol.157
, pp. 41-47
-
-
Medina-Diaz, I.M.1
Elizondo, G.2
-
15
-
-
33845937674
-
Pregnane X receptor-dependent induction of the CYP3A4 gene by o,p0-1,1,1,-trichloro-2,2-bis (p-chlorophenyl)ethane
-
(doi:10.1124/dmd.106.011759)
-
Medina-Diaz IM, Arteaga-Illan G, de Leon MB, Cisneros B, Sierra-Santoyo A, Vega L, Gonzalez FJ & Elizondo G 2007 Pregnane X receptor-dependent induction of the CYP3A4 gene by o,p0-1,1,1,-trichloro-2,2-bis (p-chlorophenyl)ethane. Drug Metabolism and Disposition 35 95-102. (doi:10.1124/dmd.106.011759)
-
(2007)
Drug Metabolism and Disposition
, vol.35
, pp. 95-102
-
-
Medina-Diaz, I.M.1
Arteaga-Illan, G.2
De Leon, M.B.3
Cisneros, B.4
Sierra-Santoyo, A.5
Vega, L.6
Gonzalez, F.J.7
Elizondo, G.8
-
16
-
-
45549092690
-
Pregnane X receptor protects HepG2 cells from BaP-induced DNA damage
-
(doi:10.1093/toxsci/kfn058)
-
Naspinski C, Gu X, Zhou GD, Mertens-Talcott SU, Donnelly KC & Tian Y 2008 Pregnane X receptor protects HepG2 cells from BaP-induced DNA damage. Toxicological Sciences 104 67-73. (doi:10.1093/toxsci/kfn058)
-
(2008)
Toxicological Sciences
, vol.104
, pp. 67-73
-
-
Naspinski, C.1
Gu, X.2
Zhou, G.D.3
Mertens-Talcott, S.U.4
Donnelly, K.C.5
Tian, Y.6
-
17
-
-
0023633243
-
The effect of o,p0-DDD on adrenal steroid replacement therapy requirements
-
(doi:10.1111/j.1365-2265.1987.tb01171.x)
-
Robinson BG, Hales IB, Henniker AJ, Ho K, Luttrell BM, Smee IR & Stiel JN 1987 The effect of o,p0-DDD on adrenal steroid replacement therapy requirements. Clinical Endocrinology 27 437-444. (doi:10.1111/j.1365-2265.1987.tb01171.x)
-
(1987)
Clinical Endocrinology
, vol.27
, pp. 437-444
-
-
Robinson, B.G.1
Hales, I.B.2
Henniker, A.J.3
Ho, K.4
Luttrell, B.M.5
Smee, I.R.6
Stiel, J.N.7
-
18
-
-
1442351143
-
Coregulator function: a key to understanding tissue specificity of selective receptor modulators
-
(doi:10.1210/er.2003-0023)
-
Smith CL & O'Malley BW 2004 Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocrine Reviews 25 45-71. (doi:10.1210/er.2003-0023)
-
(2004)
Endocrine Reviews
, vol.25
, pp. 45-71
-
-
Smith, C.L.1
O'Malley, B.W.2
-
19
-
-
33749860753
-
The endocrine disrupting chemical, diethylhexyl phthalate, activates MDR1 gene expression in human colon cancer LS174T cells
-
(doi:10.1677/joe.1.06664)
-
Takeshita A, Inagaki K, Igarashi-Migitaka J, Ozawa Y & Koibuchi N 2006 The endocrine disrupting chemical, diethylhexyl phthalate, activates MDR1 gene expression in human colon cancer LS174T cells. Journal of Endocrinology 190 897-902. (doi:10.1677/joe.1.06664)
-
(2006)
Journal of Endocrinology
, vol.190
, pp. 897-902
-
-
Takeshita, A.1
Inagaki, K.2
Igarashi-Migitaka, J.3
Ozawa, Y.4
Koibuchi, N.5
-
20
-
-
80053437888
-
Acetyl tributyl citrate, the most widely used phthalate substitute plasticizer, induces cytochrome p450 3a through steroid and xenobiotic receptor
-
(doi:10.1093/ toxsci/kfr178)
-
Takeshita A, Igarashi-Migitaka J, Nishiyama K, Takahashi H, Takeuchi Y & Koibuchi N 2011 Acetyl tributyl citrate, the most widely used phthalate substitute plasticizer, induces cytochrome p450 3a through steroid and xenobiotic receptor. Toxicological Sciences 123 460-470. (doi:10.1093/ toxsci/kfr178)
-
(2011)
Toxicological Sciences
, vol.123
, pp. 460-470
-
-
Takeshita, A.1
Igarashi-Migitaka, J.2
Nishiyama, K.3
Takahashi, H.4
Takeuchi, Y.5
Koibuchi, N.6
-
21
-
-
78650175257
-
Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR
-
(doi:10.1016/j.addr.2010.08.006)
-
Tolson AH & Wang H 2010 Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Advanced Drug Delivery Reviews 62 1238-1249. (doi:10.1016/j.addr.2010.08.006)
-
(2010)
Advanced Drug Delivery Reviews
, vol.62
, pp. 1238-1249
-
-
Tolson, A.H.1
Wang, H.2
-
22
-
-
52449133102
-
CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme
-
(doi:10.2174/138920008785821710)
-
Wang H & Tompkins LM 2008 CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Current Drug Metabolism 9 598-610. (doi:10.2174/138920008785821710)
-
(2008)
Current Drug Metabolism
, vol.9
, pp. 598-610
-
-
Wang, H.1
Tompkins, L.M.2
-
23
-
-
0035933511
-
The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity
-
(doi:10.1126/science.1060762)
-
Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA & Redinbo MR 2001 The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292 2329-2333. (doi:10.1126/science.1060762)
-
(2001)
Science
, vol.292
, pp. 2329-2333
-
-
Watkins, R.E.1
Wisely, G.B.2
Moore, L.B.3
Collins, J.L.4
Lambert, M.H.5
Williams, S.P.6
Willson, T.M.7
Kliewer, S.A.8
Redinbo, M.R.9
-
24
-
-
61549104490
-
PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics
-
(doi:10.2217/14622416.9.11.1695)
-
Zhang B, XieW& KrasowskiMD 2008 PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics 9 1695-1709. (doi:10.2217/14622416.9.11.1695)
-
(2008)
Pharmacogenomics
, vol.9
, pp. 1695-1709
-
-
Zhang, B.1
Xie, W.2
Krasowski, M.D.3
-
25
-
-
65349091444
-
The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism
-
(doi:10.1621/nrs.07001)
-
Zhou C, Verma S & Blumberg B 2009 The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nuclear Receptor Signaling 7 e001. (doi:10.1621/nrs.07001)
-
(2009)
Nuclear Receptor Signaling
, vol.7
-
-
Zhou, C.1
Verma, S.2
Blumberg, B.3
-
26
-
-
23444453717
-
Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes
-
(doi:10.1016/ j.bbamcr.2005.02.005)
-
Zucchini N, de Sousa G, Bailly-Maitre B, Gugenheim J, Bars R, Lemaire G & Rahmani R 2005 Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochimica et Biophysica Acta 1745 48-58. (doi:10.1016/ j.bbamcr.2005.02.005)
-
(2005)
Biochimica et Biophysica Acta
, vol.1745
, pp. 48-58
-
-
Zucchini, N.1
De Sousa, G.2
Bailly-Maitre, B.3
Gugenheim, J.4
Bars, R.5
Lemaire, G.6
Rahmani, R.7
|